2024

1. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

   Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1647-1663

2. Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial

   The Lancet Oncology, Vol. 25, Núm. 11, pp. 1453-1464